Logo

American Heart Association

  117
  0


Final ID: Su4010

Unsupervised Agglomerative Cluster Phenotyping of Young Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Abstract Body (Do not enter title and authors here): Introduction: Young patients with acute coronary syndrome (ACS) exhibit diverse demographic, clinical and angiographic characteristics.

Hypothesis: We hypothesized that unsupervised machine learning (ML) can identify phenotypic clusters and predict the prognosis among young patients with ACS who undergo percutaneous coronary intervention (PCI).

Methods: We used the Houston Methodist Young-ACS PCI registry (2010-2022) and performed agglomerative clustering to analyze demographic, clinical and angiographic variables among young patients (≤50 years) treated with PCI for ACS.

Results: Among 633 patients, cluster analysis identified three distinct phenotypes. Low risk (n=273) exhibited lowest proportions of heart failure (HF: 10.3%) and peripheral arterial disease (PAD): 5.9%), normal left ventricular ejection fraction (LVEF) (median =0.60) and shorter median culprit vessel stent length (16 mm). Moderate risk (n=101) was characterized by moderate rates of diabetes (36.6%), hypertension (77.2%), prior myocardial infarction (16.8%) and prior PCI (18.8%). High risk (n=78) had highest proportion of diabetes (67.9%), hypertension (93.6%), HF (65.4%), PAD (17.9%), prior MI (41.0%), prior PCI (46.2%), the lowest median LVEF (0.3) and the most frequent use of mechanical circulatory device (5.1%). All-cause mortality differed significantly (Figure), with high-risk cluster showing a four-fold increase in all-cause mortality (HR: 4.50 [1.68-12.1]). There was no significant difference in mortality between moderate and low-risk clusters (HR: 1.52 [0.44-5.19]).

Conclusions: Through unsupervised ML, we identified three distinct phenotypic clusters among young patients with ACS treated with PCI, each exhibiting varying degrees of comorbidity burden and allowing identification of patients with high mortality risk, thus underscoring the potential for phenotype-guided therapeutic approaches.
  • Maqsood, Muhammad Haisum  ( Houston Methodist Hospital , Houston , Texas , United States )
  • Kleiman, Neal  ( Houston Methodist , Houston , Texas , United States )
  • Khan, Safi  ( Houston Methodist Hospital , Houston , Texas , United States )
  • Bou Chaaya, Rody  ( Houston Methodist , Houston , Texas , United States )
  • Patel, Kershaw  ( Houston Methodist , Houston , Texas , United States )
  • Samimi, Sahar  ( Houston Methodist Hospital , Houston , Texas , United States )
  • Hatab, Taha  ( Houston Methodist Hospital , Houston , Texas , United States )
  • Qamar, Fatima  ( Houston Methodist , Houston , Texas , United States )
  • Kharsa, Chloe  ( Houston Methodist Hospital , Houston , Texas , United States )
  • Goel, Sachin  ( Houston Methodist Hospital , Houston , Texas , United States )
  • Shah, Alpesh  ( Houston Methodist Hospital , Houston , Texas , United States )
  • Author Disclosures:
    Muhammad Haisum Maqsood: DO NOT have relevant financial relationships | Neal Kleiman: DO have relevant financial relationships ; Researcher:medtronic:Active (exists now) ; Researcher:Abbott:Active (exists now) ; Researcher:Boston Scientific:Active (exists now) ; Researcher:Edwards LS:Active (exists now) | Safi Khan: No Answer | Rody Bou Chaaya: DO NOT have relevant financial relationships | Kershaw Patel: DO have relevant financial relationships ; Consultant:Novo Nordisk:Active (exists now) | Sahar Samimi: DO NOT have relevant financial relationships | Taha Hatab: DO NOT have relevant financial relationships | Fatima Qamar: DO NOT have relevant financial relationships | Chloe Kharsa: No Answer | Sachin Goel: No Answer | alpesh shah: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Interventional Considerations in the ACS Patient

Sunday, 11/17/2024 , 11:30AM - 12:30PM

Abstract Poster Session

More abstracts on this topic:
Absence of standard modifiable risk factors (SMuRF-less) among 5002 Middle Eastern patients with atherosclerotic cardiovascular disease: (Interim analysis from the Jo-SMuRF Study)

Aldalal'ah Mo'men, Hammoudeh Ayman, Hamza Ibrahem, Alqudah Mohammad, Khasawneh Hasan, Alomari Sawsan, Alomari Ahmad, H. Assaf Sarah, Zaqqa Ayah, Khatatbeh Moawiah

A Novel Multivariate Scoring System for Diagnosing Post-Myocardial Infarction Pericarditis Following Percutaneous Coronary Intervention

Bolaji Olayiwola, Omoru Okiemute, Upreti Prakash, Echari Blanche, Shoar Saeed, Basit Jawad, Alraies M Chadi

More abstracts from these authors:
Cardiovascular Residual Risk: Case Presentation

Maqsood Muhammad Haisum, Safarova Maya

Hemodynamic Insights Using Pressure Volume Loops into Transcatheter Repair Effects on Left Ventricular Function in Patients with Primary Mitral Regurgitation

Nagueh Sherif, Pournazari Payam, Wessly Priscilla, Hatab Taha, Bhimaraj Arvind, Faza Nadeen, Little Stephen, Goel Sachin

You have to be authorized to contact abstract author. Please, Login
Not Available